Hot Biotech Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD), Chelsea Therapeutics (NASDAQ:CHTP)

MannKind Corporation (NASDAQ:MNKD) loss of 14 cents per share in the first quarter of 2014 was wider than the Zacks Consensus Estimate by a penny but narrower than the year-ago loss by a penny. MannKind Corporation (NASDAQ:MNKD) did not generate any revenue in the first quarter of 2014, as in the year-ago quarter. Research and development (R&D) expenses remained flat at $26.2 million in the … Continue reading Hot Biotech Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD), Chelsea Therapeutics (NASDAQ:CHTP)

Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sprint Corporation (NYSE:S), Facebook (NASDAQ:FB), 58.com Inc (ADR) (NYSE:WUBA)

Arena Pharmaceuticals, Inc (NASDAQ:ARNA) shares fell 5.1% during trading on Monday after the company announced weaker than expected quarterly earnings, AnalystRatings Network reports. The company traded as low as $6.82 and last traded at $6.82, with a volume of 4,382,908 shares. The stock had previously closed at $7.19. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -4.87% in last session and finished the day at $6.84. … Continue reading Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sprint Corporation (NYSE:S), Facebook (NASDAQ:FB), 58.com Inc (ADR) (NYSE:WUBA)

Investment analysts at JPMorgan Chase & Co. dropped their target price on shares of VIVUS (NASDAQ:VVUS) from $8.00 to $5.00 in a note issued to investors on Tuesday, Stock Ratings Network reports. JPMorgan Chase & Co.’s price target would indicate a potential downside of 10.15% from the company’s current price. VIVUS, Inc. (NASDAQ:VVUS)stock performance was 7.23% in last session and finished the day at $ … Continue reading Hot Biotech Stocks: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD)

Endocyte (NASDAQ:ECYT)’s shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings, American Banking and Market News reports. 13,778,961 shares changed hands during trading, an increase of 624% from the previous session’s volume of 1,903,723 shares. Endocyte, Inc. (NASDAQ:ECYT) stock performance was 61.91% in last session and finished the day at $ 6.62. Traded volume was 17,639,435 shares in … Continue reading Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

VIVUS Inc (NASDAQ:VVUS) will be announcing its Q114 earnings results on Monday, May 5th. Analysts expect the company to announce earnings of ($0.37) per share and revenue of $11.40 million for the quarter. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -2.12% in last session and finished the day at $5.09. Traded volume was 1.34million shares in the last session and the average volume of the stock … Continue reading Hot Biotech Movers: VIVUS (NASDAQ:VVUS), MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was 0.32% in last session and finished the day at $6.20. Traded volume was 4.92million shares in the last session and the average volume of the stock remained 5.60million shares. The beta … Continue reading Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott Laboratories (NYSE:ABT), UnitedHealth Group (NYSE:UNH), AstraZeneca (NYSE:AZN)